ArticleBioengineering (Basel, Switzerland)2026
Improving Normal/Abnormal and Benign/Malignant Classifications in Mammography with ROI-Stratified Deep Learning.
Article in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Deep Learning (DL) has undergone widespread adoption for medical image analysis and diagnosis. Numerous studies have explored mammographic image analysis for breast cancer screening. For this study, we assessed the hypothesis that stratifying mammography images based on the presence or absence of a corresponding region of interest (ROI) improves classification accuracy for both normal-abnormal and benign-malignant classifications. Our methodology involves independently training models and performing predictions on each subgroup with subsequent integration of the results. We used several DL models, including ResNet, EfficientNet, SwinTransformer, ConvNeXt, and MobileNet. For experimentation, we used the publicly available VinDr., CDD-CESM, and DMID datasets. Our comparison with prediction results obtained without ROI-based stratification demonstrated that the utility of considering ROI presence to enhance diagnostic accuracy in mammography increases along with the data volume. These findings support the usefulness of our stratification approach, particularly as a dataset's size grows.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.